Cohort Dashboard

GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.

Total Global Data

0
Unique Locations
0
Cohorts
0
Samples Expected
0
Samples Completed

Last Updated: January 14, 2023 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova

Showing 10 of 227 cohort studies.

ADepT-PD

University College London | London, United Kingdom
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 408 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 408 Expected

AfrAbia-PD Genomic Consortium (AA-PDGC)

Kulliyyah Of Medicine of International Islamic University Malaysia | Kuantan, Malaysia
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 100 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 100 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 200 Expected

ANANEOS Study

Ionian University, Altoida Inc. | Corfu, Greece
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 300 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 300 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 600 Expected

APGS

QIMR Berghofer Medical Research Institute | Brisbane, Australia
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

1,414 Completed out of 10,000 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 10,000 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

1,414 Completed out of 20,000 Expected
Ancestry Breakdown for Samples Completed
Show

Arizona Brain Bank Brain and body donation programme (BBDP)

Banner Sun Health Research Institution | Phoenix, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

230 Completed out of 324 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

470 Completed out of 100 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

700 Completed out of 424 Expected
Ancestry Breakdown for Samples Completed
Show

AUTH - GP2 study

Aristotle University of Thessaloniki | Thessaloniki, Greece
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 100 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 60 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 160 Expected

BADGE-PD

Assistance Publique Hôspitaux de Paris | Paris, France
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 304 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 304 Expected

Baylor College of Medicine (BCM)

Baylor College of Medicine | Houston, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

537 Completed out of 553 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

251 Completed out of 255 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

788 Completed out of 808 Expected
Ancestry Breakdown for Samples Completed
Show

BCM-UMD

University of Maryland | College Park, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

357 Completed out of 357 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

87 Completed out of 88 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

444 Completed out of 445 Expected
Ancestry Breakdown for Samples Completed
Show

BERN

Inselspital Bern | Bern, Switzerland
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

Pending
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

Pending
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 0 Expected

Submit a Cohort

If you would like to collaborate with GP2, reach out to submit a cohort or get more information on how to become a member.

Request AMP® PD Data Set

As GP2 completes cohort genotyping, all data is shared through the secured AMP® PD platform. Register to request access to this data.

Discover GP2 Members from Around the Globe

Explore the organizational members that make our research possible through their collaboration and contribution of samples and data.